303 related articles for article (PubMed ID: 20862519)
1. Prevention of age-related macular degeneration.
Wong IY; Koo SC; Chan CW
Int Ophthalmol; 2011 Feb; 31(1):73-82. PubMed ID: 20862519
[TBL] [Abstract][Full Text] [Related]
2. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
3. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
4. Nutritional supplements for age-related macular degeneration.
Krishnadev N; Meleth AD; Chew EY
Curr Opin Ophthalmol; 2010 May; 21(3):184-9. PubMed ID: 20216418
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
6. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
7. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration.
Sin HP; Liu DT; Lam DS
Acta Ophthalmol; 2013 Feb; 91(1):6-11. PubMed ID: 22268800
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
10. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
[TBL] [Abstract][Full Text] [Related]
12. Nutritional supplementation in age-related macular degeneration.
Coleman H; Chew E
Curr Opin Ophthalmol; 2007 May; 18(3):220-3. PubMed ID: 17435429
[TBL] [Abstract][Full Text] [Related]
13. Nutrition and the aging retina: A comprehensive review of the relationship between nutrients and their role in age-related macular degeneration and retina disease prevention.
Walchuk C; Suh M
Adv Food Nutr Res; 2020; 93():293-332. PubMed ID: 32711865
[TBL] [Abstract][Full Text] [Related]
14. [Nutrition and age-related macular degeneration].
Desmettre T; Lecerf JM; Souied EH
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S38-56. PubMed ID: 15602406
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
Marshall LL; Roach JM
Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
[TBL] [Abstract][Full Text] [Related]
16. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
Chiu CJ; Milton RC; Klein R; Gensler G; Taylor A
Ophthalmology; 2009 May; 116(5):939-46. PubMed ID: 19410952
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration.
Cho E; Hankinson SE; Rosner B; Willett WC; Colditz GA
Am J Clin Nutr; 2008 Jun; 87(6):1837-43. PubMed ID: 18541575
[TBL] [Abstract][Full Text] [Related]
18. Nutritional supplementation and age-related macular degeneration.
Olson JH; Erie JC; Bakri SJ
Semin Ophthalmol; 2011 May; 26(3):131-6. PubMed ID: 21609225
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
Wang JJ; Buitendijk GH; Rochtchina E; Lee KE; Klein BE; van Duijn CM; Flood VM; Meuer SM; Attia J; Myers C; Holliday EG; Tan AG; Smith WT; Iyengar SK; de Jong PT; Hofman A; Vingerling JR; Mitchell P; Klein R; Klaver CC
Ophthalmology; 2014 Mar; 121(3):667-75. PubMed ID: 24290803
[TBL] [Abstract][Full Text] [Related]
20. ω-3 Fatty acids and lutein + zeaxanthin supplementation for the prevention of cardiovascular disease.
Rizos EC; Ntzani EE
JAMA Intern Med; 2014 May; 174(5):771-2. PubMed ID: 24638082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
